[1] Ljungberg B,Campbell S C, Choi H Y, et al. The epidemiology of renal cell carcinoma[J]. Eur Urol, 2011, 60(4): 615-621.
[2] Qayyum T, McArdle P A, Lamb G W, et al. Prospective study of the role of inflammation in renal cancer[J]. Urol Int, 2012, 88(3): 277-281.
[3] Lederle F A. The rise and fall of abdominal aortic aneurysm[J]. Circulation, 2011, 124(10): 1097-1099.
[4] Hinterseher I, Kuffner H, Koch R, et al. Comparison of survival rates for abdominal aortic aneurysm treatment methods[J]. World J Surg, 2012,36(4): 917-922.
[5] Coselli J S, Conklin L D, Lemaire S A. Thoracoabdominal aortic aneurysm repair: review and update of current strategies[J]. Ann Thorac Surg, 2002,74(5): S1881-S1884.
[6] Derrow A E, Seeger J M, Dame D A, et al. The outcome in the united states after thoracoabdominal aortic aneurysm repair, renal artery bypass, and mesenteric revascularization[J]. J Vasc Surg, 2001, 34(1): 54-61.
[7] Marrocco-Trischitta M M, Scicchitano G, Acconcia A, et al. Management of synchronous abdominal aortic aneurysm and renal carcinoma associated with duplication of the inferior vena cava[J]. J Cardiovasc Surg, 2001, 42(5): 683-685.
[8] Veraldi G F, Tasselli S, De Manzoni G, et al. Surgical treatment of abdominal aortic aneurysm with concomitant renal cell carcinoma: a single-centre experiencewith review of the literature[J]. J Cardiovasc Surg, 2006, 47(6): 643-649.
[9] 法朋燕,刘华, 郑君芳,等. NHERF3在肾癌组织中的表达变化及其意义[J]. 首都医科大学学报, 2015,36(2):251-254. |
